- Home
- FTHM vs NRXS Comparison
FTHM vs NRXS Comparison
Compare FTHM & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | FTHM | NRXS |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.4M | 49.0M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | FTHM | NRXS |
|---|---|---|
| Price | $0.96 | $4.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.50 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 230.6K | 105.4K |
| Earning Date | 03-11-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $421,612,000.00 | $3,362,320.00 |
| Revenue This Year | $30.07 | $31.05 |
| Revenue Next Year | $14.66 | $137.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 32.78 | ★ 36.89 |
| 52 Week Low | $0.65 | $1.33 |
| 52 Week High | $3.37 | $6.20 |
Technical Indicators
Market Signals| Indicator | FTHM | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 32.67 | 50.06 |
| Support Level | $1.25 | $4.13 |
| Resistance Level | $1.30 | $4.82 |
| Average True Range (ATR) | 0.11 | 0.33 |
| MACD | -0.04 | -0.11 |
| Stochastic Oscillator | 3.85 | 23.78 |
Price Performance
Historical ComparisonAbout FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).